A Charité spin-offPrecision Starts Here.
Precision Starts Here.
One platform, two clear benefits.
CureNavi connects patients and their treating physician with the specialists of leading academic cancer centers — so that every patient gets access to the genomic tests and clinical trials their case calls for. We use AI to turn your medical history into a clear picture the specialists can act on.
For patients and families
- Access to genomic testing if relevant to your diagnosis.
- A clear view of the clinical trials that may be open to you.
- Free to use. Funded by research partners - never by you.
For office-based physicians
- Decision support aligned with the latest guidelines and active trial protocols.
- Less time spent compiling files; more time with your patient.
- A direct line to the specialists at our partner cancer centers.
Three steps. One clear recommendation.
You share your files and your doctor's contact details
You create an account, upload your medical documents and give us the contact of the treating physician who should receive our recommendations. You stay in control of your data at every step.
CureNavi structures your data and matches it against current options
Our system reads your file, structures it to medical data standards and checks against current guidelines and active clinical trials whether genomic testing is recommended and which trials may be a fit.
A specialist reviews and sends a clear recommendation
A specialist from our partner cancer center validates the analysis and shares an actionable recommendation with you and your doctor. If a trial is a fit, we put you in touch with the trial center only with your explicit consent.
Clinical authority, by design.
- Built as a spin-off of Charité Berlin.
- Every recommendation is explainable, traceable and physician-validated.
- GDPR-compliant by design. All data processing stays in the EU.
A spin-off of Charité Berlin, in partnership with its Department of Urology.
Launching with prostate cancer, scaling from there.
We are launching our first version for prostate cancer at Charité's Department of Urology, with a focus on access to genomic testing and clinical trial matching. Over the following months we will extend to further urological and molecularly driven cancer entities, and we will add personalised treatment recommendations as a next step.
Pick the path that fits you.
Whether you are a patient looking for access to a trial or genomic testing, or a physician interested in joining the network, we'd love to hear from you.
I am a patient or family member
Create your account and connect with a specialist cancer center through your treating physician.
Register →I am a physician
Join the network to give your patients access to specialist recommendations on genomic testing and trials.
Register →Our mission.
CureNavi makes precision oncology accessible by connecting patients, their treating physicians, and leading cancer specialists on a single, trusted platform. We do this without charging patients or hospitals: the service is funded by the value of the anonymised real-world evidence we generate.
The team.
Gaëlle Waltinger
Formerly VP Europe at Bausch+Lomb, prior experience at Novartis. INSEAD & ESCP graduate.
Prof. Dr. Thorsten Schlomm
Director of the Urology Clinic at Charité Berlin and founder of DNA-Med.
Jonathan Jeutner
Physician specialising in Urology at Charité, founder of My Tuko. LL.B. and B.Sc. from LSE.
Dr. Nadine Biernath
Physician at the Urology Clinic of Charité Berlin, specialist in clinical genetics.
Frequently asked questions.
Get in touch.
We read every message. Tell us briefly who you are and how we can help. We will get back to you within a few working days.
For patients and families
If you would like access to genomic testing or a clinical trial through CureNavi, please reach out. We will guide you through the next steps.
For physicians
If you are an office-based urologist or oncologist and would like to join the network, write to us. We will set up a short call.
CureNavi GmbH
Berlin, Germany
info@curenavi.com